SV2 PET Imaging With [11C]APP311

Recruiting now

Conditions studied: Schizophrenia and Other Psychotic Disorders, Cannabis Use Disorder, Healthy

In brief

The aim of this study is to evaluate a new SV2A tracer, \[11C\]APP311, in healthy aging and neuropsychiatric disorders including psychotic disorders and cannabis use disorders.

Key facts

Study ID

NCT03995121

Run by

Yale University

People needed

250

Starts

2017-12-01

Expected to finish

2026-12-01

Last updated by the study team

2026-01-28

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Willing and able to give voluntary written informed consent
• Male and Female subjects, age 18 to 65 years, inclusive

You may not qualify if…

• MRI metal exclusions and claustrophobia.
• Education completed is less than 12 years

Where it is running

• Conneticut Mental Health Center — New Haven, Connecticut, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.